These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16637830)

  • 1. Developments in molecular genetics and electrophysiology in inherited retinal disorders.
    Andréasson S
    Acta Ophthalmol Scand; 2006 Apr; 84(2):161-8. PubMed ID: 16637830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes.
    Phelan JK; Bok D
    Mol Vis; 2000 Jul; 6():116-24. PubMed ID: 10889272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental therapeutic modalities for retinitis pigmentosa].
    Banin E; Chowers I
    Harefuah; 2004 May; 143(5):368-71, 389. PubMed ID: 15190851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review and update: current treatment trends for patients with retinitis pigmentosa.
    Shintani K; Shechtman DL; Gurwood AS
    Optometry; 2009 Jul; 80(7):384-401. PubMed ID: 19545852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing B-wave amplitude noted in erg in one type of retinitis pigmentosa.
    Schoon DV; Harris M
    Metab Pediatr Syst Ophthalmol; 1982; 6(2):107-15. PubMed ID: 7162425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signs of Oguchi Disease and Pigmentary Degeneration from Early in Life.
    Nishiguchi KM; Kunikata H; Nakazawa T
    Ophthalmology; 2020 Jun; 127(6):825. PubMed ID: 32444022
    [No Abstract]   [Full Text] [Related]  

  • 8. [Retinal protection using glasses filtering short wave lengths in patients with hereditary degenerative diseases. First electrophysiologic results].
    Le Gargasson JF; Rigaudière F; Grall Y; Pizzato M; Keller J; Ingster-Moati I
    Ophtalmologie; 1989; 3(1):65-6. PubMed ID: 2641074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic eye diseases. Retinitis pigmentosa and other inherited eye disorders. Proceedings of the International Symposium on Genetics and Ophthalmology. Held in Jerusalem, Israel, September 1981.
    Birth Defects Orig Artic Ser; 1982; 18(6):1-746. PubMed ID: 7171747
    [No Abstract]   [Full Text] [Related]  

  • 10. Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium.
    Radtke ND; Aramant RB; Petry HM; Green PT; Pidwell DJ; Seiler MJ
    Am J Ophthalmol; 2008 Aug; 146(2):172-182. PubMed ID: 18547537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-wave in the ERG and the EPG (electropupillogram) in pigmentary degeneration of the retina.
    Tamai A
    Yonago Acta Med; 1967 Oct; 11(3):256-61. PubMed ID: 5592208
    [No Abstract]   [Full Text] [Related]  

  • 12. ELECTROPHYSIOLOGIC ASPECTS OF SEVERAL RETINAL DISEASES.
    CARR RE; SIEGEL IM
    Am J Ophthalmol; 1964 Jul; 58():95-107. PubMed ID: 14177989
    [No Abstract]   [Full Text] [Related]  

  • 13. Attenuation of vision loss and delay in apoptosis of photoreceptors induced by proinsulin in a mouse model of retinitis pigmentosa.
    Corrochano S; Barhoum R; Boya P; Arroba AI; Rodríguez-Muela N; Gómez-Vicente V; Bosch F; de Pablo F; de la Villa P; de la Rosa EJ
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4188-94. PubMed ID: 18515565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-based therapies to limit photoreceptor degeneration.
    Lund R
    Arch Soc Esp Oftalmol; 2008 Aug; 83(8):457-64. PubMed ID: 18661440
    [No Abstract]   [Full Text] [Related]  

  • 15. From basic to clinical research: a journey with the retina, the retinal pigment epithelium, the cornea, age-related macular degeneration and hereditary degenerations, as seen in the rear view mirror.
    Nilsson SE
    Acta Ophthalmol Scand; 2006 Aug; 84(4):452-65; 451. PubMed ID: 16879565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical disorders affecting mesopic vision.
    Petzold A; Plant GT
    Ophthalmic Physiol Opt; 2006 May; 26(3):326-41. PubMed ID: 16684159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preferential representation of photopic function at the level of the visual evoked potential].
    Rigal D; Sole P; Rouher F; Alfieri R
    Bull Soc Ophtalmol Fr; 1972; 72(7):783-8. PubMed ID: 4661351
    [No Abstract]   [Full Text] [Related]  

  • 18. Preservation of macular oscillatory potentials in eyes of patients with retinitis pigmentosa and normal visual acuity.
    Ikenoya K; Kondo M; Piao CH; Kachi S; Miyake Y; Terasaki H
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3312-7. PubMed ID: 17591903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental therapeutic modalities for retinitis pigmentosa].
    Chowers I; Banin E
    Harefuah; 2003 Apr; 142(4):277-80, 317. PubMed ID: 12754878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crb1 is a determinant of retinal apical Müller glia cell features.
    van de Pavert SA; Sanz AS; Aartsen WM; Vos RM; Versteeg I; Beck SC; Klooster J; Seeliger MW; Wijnholds J
    Glia; 2007 Nov; 55(14):1486-97. PubMed ID: 17705196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.